Radius Health to Release Fourth Quarter and Full Year 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, February 24, 2022
February 15, 2022 12:00 ET
|
Radius Health Inc.
BOSTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ: RDUS) announced today that it will release its fourth quarter and full year 2021 financial results on Thursday, February 24,...
Radius Health Completes Business Adjustment
January 13, 2022 09:00 ET
|
Radius Health Inc.
Completion of three pivotal trials in 2021 enables restructuring of the operating infrastructureNon-Sales headcount reduced by approximately 20%Reductions focused on areas that supported abaloparatide...
Radius Announces Update on TYMLOS® (abaloparatide) Label
December 23, 2021 08:30 ET
|
Radius Health Inc.
FDA approved the removal of the boxed warning from the TYMLOS label, effective December 22, 2021The boxed warning had referred to the potential risk of osteosarcomaAction follows review of long-term...
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021
December 08, 2021 10:15 ET
|
Radius Health Inc.
Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine...
Radius Health to Host Conference Call Today, Wednesday, December 8, 2021
December 08, 2021 09:00 ET
|
Radius Health Inc.
BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) announced it will host a conference call today, Wednesday, December 8, 2021, at 4:00 p.m. ET...
Radius Announces Results from the wearABLe Trial Evaluating Abaloparatide Transdermal System in Postmenopausal Women with Osteoporosis
December 08, 2021 09:00 ET
|
Radius Health Inc.
The wearABLe study did not demonstrate non-inferiority of abalo-TDS to TYMLOS®Lumbar spine BMD at 12 months vs. baseline for abalo-TDS was +7.1% vs. TYMLOS +10.9%Both abalo-TDS and TYMLOS 12-month...
Radius Health to Participate in the Stifel 2021 Virtual Healthcare Conference
November 11, 2021 08:30 ET
|
Radius Health Inc.
BOSTON, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) today announced that management will participate in the Stifel 2021 Virtual Healthcare...
Radius Health, Inc.: Third Quarter 2021 Results
November 08, 2021 08:00 ET
|
Radius Health Inc.
TYMLOS® Q3, 2021 net revenue: $57 million, +13% vs. Q3, 2020Added 4,461 new patients on TYMLOS in Q3, 2021, +10% vs. Q3, 2020Adjusted EBITDA of ($11) million vs. $9 million in Q3, 2020 which included...
CORRECTING and REPLACING -- Radius Health to Announce Third Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Monday, November 8, 2021
October 21, 2021 13:15 ET
|
Radius Health Inc.
BOSTON, Oct. 21, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline yesterday, Oct. 20, by Radius Health, Inc. (NASDAQ: RDUS), please note that the dial-in numbers were listed...
Radius Health to Announce Third Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Monday, November 8, 2021
October 20, 2021 15:00 ET
|
Radius Health Inc.
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ: RDUS) announced today that it will release its third quarter financial results on Monday, November 8, 2021. The Company will...